136 related articles for article (PubMed ID: 21570813)
1. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on enteroaggregative Escherichia coli and the role of the surface protein dispersin.
Mortensen NP; Fowlkes JD; Maggart M; Doktycz MJ; Nataro JP; Drusano G; Allison DP
Int J Antimicrob Agents; 2011 Jul; 38(1):27-34. PubMed ID: 21570813
[TBL] [Abstract][Full Text] [Related]
2. Enteroaggregative Escherichia coli: surface protein dispersin increases bacterial uptake of ciprofloxacin.
Mortensen NP; Boisen N; Carey S; Kennel SJ; Fowlkes JD; Doktycz MJ; Nataro JP; Allison DP
Int J Antimicrob Agents; 2013 Nov; 42(5):462-5. PubMed ID: 24011504
[TBL] [Abstract][Full Text] [Related]
3. Effects of subinhibitory concentrations of amikacin and ciprofloxacin on the hydrophobicity and adherence to epithelial cells of uropathogenic Escherichia coli strains.
Wojnicz D; Jankowski S
Int J Antimicrob Agents; 2007 Jun; 29(6):700-4. PubMed ID: 17382520
[TBL] [Abstract][Full Text] [Related]
4. Evolution of antimicrobial resistance in enteroaggregative Escherichia coli and enterotoxigenic Escherichia coli causing traveller's diarrhoea.
Mendez Arancibia E; Pitart C; Ruiz J; Marco F; Gascón J; Vila J
J Antimicrob Chemother; 2009 Aug; 64(2):343-7. PubMed ID: 19474067
[TBL] [Abstract][Full Text] [Related]
5. Measuring cell surface elasticity on enteroaggregative Escherichia coli wild type and dispersin mutant by AFM.
Beckmann MA; Venkataraman S; Doktycz MJ; Nataro JP; Sullivan CJ; Morrell-Falvey JL; Allison DP
Ultramicroscopy; 2006; 106(8-9):695-702. PubMed ID: 16682120
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistant enteroaggregative Escherichia coli diarrhoea in rural southern Indian population.
Raju B; Ballal M
Scand J Infect Dis; 2009; 41(2):105-8. PubMed ID: 19107675
[TBL] [Abstract][Full Text] [Related]
7. Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli.
Jerman B; Butala M; Zgur-Bertok D
Antimicrob Agents Chemother; 2005 Jul; 49(7):3087-90. PubMed ID: 15980407
[TBL] [Abstract][Full Text] [Related]
8. In vivo selection of an Escherichia coli isolate highly resistant to ciprofloxacin and ceftazidime: role of a 4-bp duplication in acrR and ampC overexpression.
Corvec S; Lepelletier D; Reynaud A; Dauvergne S; Giraudeau C; Caroff N
Int J Antimicrob Agents; 2008 Aug; 32(2):196-8. PubMed ID: 18571906
[No Abstract] [Full Text] [Related]
9. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
Coban AY; Bayram Z; Sezgin FM; Durupinar B
Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
[TBL] [Abstract][Full Text] [Related]
10. Composition of the outer membrane proteins of Escherichia coli strains in relation to serum susceptibility after exposure to subinhibitory concentrations of amikacin and ciprofloxacin.
Wojnicz D; Cisowska A
Int J Antimicrob Agents; 2009 Jun; 33(6):579-82. PubMed ID: 19232480
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
Zhao X; Quinn B; Kerns R; Drlica K
J Antimicrob Chemother; 2006 Dec; 58(6):1283-6. PubMed ID: 17003060
[TBL] [Abstract][Full Text] [Related]
12. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
[TBL] [Abstract][Full Text] [Related]
13. Characterization of enteroaggregative Escherichia coli (EAEC) clinical isolates and their antibiotic resistance pattern.
Aslani MM; Alikhani MY; Zavari A; Yousefi R; Zamani AR
Int J Infect Dis; 2011 Feb; 15(2):e136-9. PubMed ID: 21130676
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
Hostacká A
Microbios; 1997; 91(368-369):137-43. PubMed ID: 9523422
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic-mediated recombination: ciprofloxacin stimulates SOS-independent recombination of divergent sequences in Escherichia coli.
López E; Elez M; Matic I; Blázquez J
Mol Microbiol; 2007 Apr; 64(1):83-93. PubMed ID: 17376074
[TBL] [Abstract][Full Text] [Related]
16. The Escherichia coli efflux pump TolC promotes aggregation of enteroaggregative E. coli 042.
Imuta N; Nishi J; Tokuda K; Fujiyama R; Manago K; Iwashita M; Sarantuya J; Kawano Y
Infect Immun; 2008 Mar; 76(3):1247-56. PubMed ID: 18160483
[TBL] [Abstract][Full Text] [Related]
17. The combination of the SH metabolite of erdosteine (a mucoactive drug) and ciprofloxacin increases the inhibition of bacterial adhesiveness achieved by ciprofloxacin alone.
Dal SM; Bovio C; Culici M; Braga PC
Drugs Exp Clin Res; 2002; 28(2-3):75-82. PubMed ID: 12224380
[TBL] [Abstract][Full Text] [Related]
18. The majority of enteroaggregative Escherichia coli strains produce the E. coli common pilus when adhering to cultured epithelial cells.
Avelino F; Saldaña Z; Islam S; Monteiro-Neto V; Dall'Agnol M; Eslava CA; Girón JA
Int J Med Microbiol; 2010 Nov; 300(7):440-8. PubMed ID: 20452276
[TBL] [Abstract][Full Text] [Related]
19. [Susceptibility to antimicrobial agents of enteroaggregative Escherichia coli strains isolated from children with diarrhea].
Sobieszczańska B; Kowalska-Krochmal B; Mowszet K; Pytrus T
Przegl Epidemiol; 2003; 57(3):499-503. PubMed ID: 14682169
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
Gualco L; Schito AM; Schito GC; Marchese A
Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
